1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S556000

Reexamination Certificate

active

10276646

ABSTRACT:
Compound corresponding to the general formula (I)in which X represents an oxygen or sulphur atom or an NH group and R1, R2, R3and R4each represent a hydrogen or halogen atom or a nitro, amino, trifluoromethyl, trifluoroalkoxy, cyano, hydroxyl, (C1–C6)alkyl, (C1–C6)alkoxy or phenyl group.Application in therapeutics.

REFERENCES:
patent: 5478939 (1995-12-01), Trybulski et al.
patent: 6407095 (2002-06-01), Lochead et al.
patent: 6809094 (2004-10-01), O'Neill et al.
patent: 2002/0086871 (2002-07-01), O'Neill et al.
patent: 0307140 (1989-03-01), None
patent: WO 00/34279 (2000-06-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3743005

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.